1726 - 1750 of 8436 Results
Title
Year
-
OPENTitle: Analysis of Y chromosome haplogroups in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac277Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac277/47057066/fcac277.pdfCitation Count: 7
- Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites2022OPENTitle: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolitesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 378Issue #: 6618Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm3233Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9993714Citation Count: 147
-
OPENTitle: Adult-onset KMT2B-related dystoniaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac276Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac276/47057049/fcac276.pdfCitation Count: 9
- Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains2022OPENTitle: Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brainsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac274Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac274/46907691/fcac274.pdfCitation Count: 18
- Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation2022OPENTitle: Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202207022Best OA location URL: https://rupress.org/jcb/article-pdf/221/12/e202207022/1442103/jcb_202207022.pdfCitation Count: 26
- The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegeneration2022RESTRICTEDTitle: The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegenerationJournal Name: Seminars in ImmunologyPublisher: Elsevier BVVol: 61-64Issue #:Start Page: 101655End Page: 101655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smim.2022.101655Citation Count: 3
-
OPENTitle: Comparison of manual and automated measures of walking speed: Distance and pace matterJournal Name: Experimental GerontologyPublisher: Elsevier BVVol: 170Issue #:Start Page: 111987End Page: 111987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.exger.2022.111987Best OA location URL: https://doi.org/10.1016/j.exger.2022.111987Citation Count: 3
-
RESTRICTEDTitle: Management of psychiatric and cognitive complications in Parkinson’s diseaseJournal Name: BMJPublisher: BMJVol:Issue #:Start Page: e068718End Page: e068718Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/bmj-2021-068718Best OA location URL: https://www.bmj.com/content/bmj/379/bmj-2021-068718.full.pdfCitation Count: 18
-
OPENTitle: Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative LightingJournal Name: LEUKOSPublisher: Informa UK LimitedVol: 19Issue #: 3Start Page: 294End Page: 307Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15502724.2022.2123816Best OA location URL: https://doi.org/10.1080/15502724.2022.2123816Citation Count: 8
-
OPENTitle: Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility StudyJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 31Issue #: 6Start Page: 2741End Page: 2758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1044/2022_ajslp-22-00063Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911128Citation Count: 13
-
RESTRICTEDTitle: Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker StudiesJournal Name: Journal of Immigrant and Minority HealthPublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 291End Page: 305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10903-022-01411-yCitation Count: 2
-
OPENTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://www.nature.com/articles/s41531-022-00404-w.pdfCitation Count: 11
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 6
-
OPENTitle: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and functionJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113896End Page: 113896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896Citation Count: 11
-
OPENTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://www.eneuro.org/content/eneuro/9/6/ENEURO.0325-22.2022.full.pdfCitation Count: 11
-
OPENTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 12
-
OPENTitle: A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 213End Page: 222Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13603Citation Count: 3
-
OPENTitle: Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29257Best OA location URL: https://doi.org/10.1002/mds.29257Citation Count: 38
-
OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.846126/pdfCitation Count: 4
-
OPENTitle: Cognitive dysfunction 1 year after COVID‐19: evidence from eye trackingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 11Start Page: 1826End Page: 1831Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51675Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51675Citation Count: 8
-
RESTRICTEDTitle: Genetic architecture of Parkinson’s disease subtypes – Review of the literatureJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1023574Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1023574/pdfCitation Count: 19
-
OPENTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 10
-
OPENTitle: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00388-7Best OA location URL: https://www.nature.com/articles/s41531-022-00388-7.pdfCitation Count: 37
-
RESTRICTEDTitle: State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell usJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.971007Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.971007/pdfCitation Count: 2
-
RESTRICTEDTitle: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201404Citation Count: 9